Donor-Ready Hospital Model

Summary

The proposed innovation, the Donor‑Ready Hospital (DRH) model, introduces a modern, hospital‑centred framework that transforms organ donation from a fragmented, reactive process into a predictable, ethical, and high‑performance clinical system. DRH integrates the strongest global practices into a single operational standard built around early recognition, automated donor identification, specialist‑led family support, and structured donor management. It reduces clinician burden, strengthens safeguards, improves coordination, and delivers major national health and economic benefits. In essence, DRH provides hospitals with the clarity, capability, and confidence needed to deliver world‑class donation outcomes while protecting families, supporting staff, and ensuring full legal and ethical alignment.

Introduction and Global Context

Organ transplantation remains one of the most effective life‑saving interventions in modern medicine, yet the global supply of transplantable organs continues to fall dramatically short of clinical need. According to the Global Observatory on Donation and Transplantation, only around 10% of global transplant demand is currently met, leaving millions without access to life‑saving treatment (The Lancet, 2024). Even in high‑income countries with advanced healthcare systems, the gap between the number of patients on waiting lists and the number of available organs persists.

This shortfall is not primarily attributable to public attitudes. In the United States, for example, more than half of adults are registered organ donors, yet only a small fraction of deaths occur under conditions that allow donation, and many potential donors are lost due to hospital‑level process failures (Sheehy et al., 2003; Israni A, et.al., 2025). Similar patterns are observed in the United Kingdom, Australia, Canada, and across Europe.

Over the past three decades, countries have attempted to address this gap through legal reforms (e.g., opt‑out consent systems), public awareness campaigns, and the creation of national coordination bodies. Spain’s Organización Nacional de Trasplantes (ONT) is widely regarded as the most successful example of such reforms, achieving the world’s highest deceased donor rate at 49.4 donors per million population in 2023 (The Lancet, 2024). However, comparative analyses show that legal frameworks alone do not explain Spain’s success, nor do they guarantee similar outcomes elsewhere. England, Wales, France, and the Netherlands have all adopted opt‑out systems, yet none have achieved Spanish‑level donation rates, and early evaluations suggest that improvements have been modest and uneven (Rees et al., 2024).

This divergence indicates that the decisive factors lie not in legislation but in the operational performance of hospitals, where potential donors are identified, managed, and converted into actual transplants. Despite the centrality of hospitals to the donation pathway, no country has implemented a hospital‑level certification system that defines what a donation‑ready institution must achieve. This absence of structured hospital‑quality standards represents a critical gap in global organ‑donation architecture.

The Donor‑Ready Hospital (DRH) model addresses this gap by introducing a unified, auditable framework that standardises donation readiness across institutions, analogous to trauma‑centre or stroke‑centre accreditation (MacKenzie et al., 2006).

Limitations of Current National Models

Although several countries have achieved notable progress in organ donation, none has developed a comprehensive hospital‑level framework that ensures consistent performance across the entire donation pathway. Existing systems tend to excel in one or two dimensions — such as national coordination, legislative design, or specialist staffing — but they lack an integrated architecture that standardises hospital readiness, enforces best practices, and aligns incentives with donation outcomes.

Spain

Spain’s ONT model is often cited as the global benchmark, yet its success is rooted in a combination of cultural, organisational, and clinical factors rather than a formalised hospital‑quality system. Transplant coordinators embedded in intensive care units play a central role, and ONT provides strong national leadership (Matesanz & Domínguez‑Gil, 2007). However:

  • Spain does not operate a tiered hospital readiness certification model.
  • Donor management bundles are not uniformly mandated.
  • Automated donor identification triggers are not used nationally.
  • Hospital level performance dashboards are not standard.

Spain demonstrates what is possible when coordination and clinical culture are strong, but it does not provide a replicable hospital‑level framework that other countries can adopt wholesale (The Lancet, 2024).

United Kingdom

The UK has invested heavily in Specialist Nurses in Organ Donation (SNODs), who are highly trained and effective. However:

  • Hospital level processes vary widely.
  • Brain death determination delays remain common.
  • Donor management bundle compliance is inconsistent.
  • Family approach quality varies by region (NHS, 2026).

United States

The U.S. system demonstrates substantial capacity, with more than 24,000 deceased donors annually (Israni A, et.al., 2025). Yet:

  • Hospital performance varies dramatically.
  • Referral practices are inconsistent.
  • Brain death determination is often delayed.
  • Donor management varies by Organ Procurement Organizations (OPO) region.
  • No national hospital readiness certification exists (Sheehy et al., 2003; HHS, 2019).

Australia

Australia strong national coordination body (DonateLife), but:

  • Hospital level processes remain variable.
  • No unified donation readiness framework exists (Australian Organ and Tissue Authority, 2022).

Cross national pattern

Across all systems:

  • No country integrates donor identification, rapid referral, brain death determination, donor management, family support, and audit into a single hospital level standard.

This is the structural gap the DRH model fills.

Conceptual Foundations of the Donor‑Ready Hospital (DRH)

The Donor‑Ready Hospital (DRH) model is built on the recognition that organ donation is fundamentally a hospital‑based process, and that the variability observed across countries, regions, and even individual institutions stems not from differences in national legislation or public attitudes, but from the absence of a structured, standardised operational framework within hospitals themselves. Although national coordination bodies, consent systems, and public engagement campaigns play essential roles in shaping donation environments, the decisive determinants of donation performance occur at the bedside: the moment a potential donor is recognised, the speed with which referral occurs, the accuracy and timeliness of brain‑death determination, the quality of donor management, and the sensitivity and professionalism of family conversations. These processes depend on clinical teams working under intense pressure, often in emotionally charged circumstances, and they require a level of consistency and institutional support that current systems do not provide.

The conceptual foundation of DRH begins with the understanding that hospitals already possess the clinical expertise required for successful donation. Intensive care teams manage complex physiology; emergency clinicians recognise catastrophic injuries; neurologists and neurosurgeons perform brain‑death assessments; anaesthetists maintain physiological stability during retrieval; nurses provide continuous monitoring and family support; and chaplains offer spiritual and emotional guidance. What is missing is not capability, but structure. In most countries, donation readiness depends on individual champions, informal practices, and local culture rather than on a codified institutional standard. This creates wide variation in performance, even between hospitals with similar resources and patient populations. DRH addresses this gap by transforming donation from a discretionary, personality‑driven activity into a reliable, system‑driven capability.

A central conceptual pillar of DRH is standardisation. Just as trauma systems and stroke networks improved outcomes by defining explicit hospital‑level criteria, DRH establishes clear expectations for donor identification, referral, brain‑death determination, donor management, family support, and audit. This standardisation reduces unwarranted variation and ensures that every hospital capable of supporting donation operates according to evidence‑based practices. The analogy to trauma‑centre and stroke‑centre accreditation is deliberate: when hospitals were stratified into levels based on capability and certification became tied to funding, reputation, and patient outcomes, performance improved dramatically and consistently across regions (MacKenzie et al., 2006). Organ donation has never undergone a similar transformation, despite facing comparable challenges of variability, coordination, and time‑critical decision‑making.

A second conceptual foundation is integration. DRH does not create parallel processes or impose new clinical burdens; instead, it embeds donation readiness into existing clinical pathways. Automated donor‑identification triggers are integrated into electronic health records, mirroring digital alerts used successfully in sepsis and deteriorating‑patient pathways (CORE, 2009). Rapid‑referral protocols align with existing escalation systems in emergency and critical care. Brain‑death determination teams build on the expertise of neurologists and intensivists who already perform these assessments, but provide them with protected time, standardised checklists, and institutional backing (Rees et al., 2024). Donor‑management bundles formalise best practices already used intuitively by experienced ICU teams (NHS, 2026; Vail et al., 2025). Family‑approach programmes draw on evidence showing that specialist‑led conversations significantly increase consent rates (Domínguez‑Gil et al., 2017). In this way, DRH strengthens what clinicians already do, rather than adding new layers of complexity.

A third conceptual foundation is support for clinicians. Donation often unfolds during some of the most emotionally and ethically challenging moments in clinical practice. Clinicians must balance prognostic uncertainty, family distress, and time‑critical decisions. In many hospitals, they do so without structured guidance, leading to hesitation, delays, or inconsistent communication. DRH reduces this burden by providing clear pathways, defined responsibilities, and specialist support. Automated triggers reduce cognitive load; rapid‑referral protocols eliminate uncertainty; brain‑death determination teams ensure timely assessments; donor‑management bundles provide clarity during physiologically complex care; and chaplaincy integration ensures that families receive culturally and spiritually aligned support (Rees et al., 2024). By shifting responsibility from individuals to institutions, DRH protects clinicians and enhances their ability to deliver high‑quality care.

A fourth conceptual foundation is transparency and accountability. In current systems, hospital‑level donation performance is rarely visible, and clinicians often never learn whether a patient became a donor or how many lives were saved. This lack of feedback weakens motivation and obscures systemic barriers. DRH introduces hospital‑level dashboards, quarterly audits, and governance committees that make performance visible and actionable. These mechanisms are not punitive; they are designed to highlight excellence, identify structural gaps, and ensure that hospitals receive the support they need to improve. Transparency also strengthens public trust and aligns institutional incentives with donation outcomes.

Finally, DRH is grounded in compatibility with national systems. It does not require changes to consent laws, allocation rules, or national coordination structures. Instead, it provides the missing operational layer that ensures these systems function effectively inside hospitals. In Spain, DRH would complement ONT by providing a uniform hospital‑level framework beneath national coordination (Matesanz & Domínguez‑Gil, 2007). In the UK, it would strengthen the impact of Specialist Nurses in Organ Donation by giving them a predictable operational environment (NHS, 2026). In the USA, it would align hospital processes with OPO responsibilities, reducing the variability that currently limits performance (Sheehy et al., 2003; HHS, 2019). In Australia, it would provide a nationally consistent hospital framework to match DonateLife’s national strategy (Australian Organ and Tissue Authority, 2022).

Taken together, these conceptual foundations position DRH as a system‑level innovation that unifies clinical excellence, organisational structure, digital support, and governance into a coherent model. It is not an incremental improvement but a structural solution to the persistent gap between donor potential and actual transplantation.

DRH System Architecture

The architecture of a Donor‑Ready Hospital (DRH) is built around the principle that organ donation is not a single event but a longitudinal clinical pathway, beginning with the earliest signs of catastrophic neurological injury and ending with post‑retrieval audit and institutional learning. In current systems, this pathway is fragmented: some hospitals excel in donor identification but struggle with family approach; others perform brain‑death determination efficiently but lack consistent donor‑management practices; still others have strong OPO relationships but weak internal governance. The DRH model resolves this fragmentation by defining a unified, auditable operational structure that ensures every stage of the donation pathway is executed reliably, consistently, and in alignment with evidence‑based practice.

At the core of this architecture is a set of ten interconnected components, each representing a critical stage in the donation process. These components are not independent modules; they form a tightly coupled system in which the performance of one stage directly influences the next. For example, early recognition and automated identification determine whether rapid referral is possible; timely referral shapes the feasibility of brain‑death determination; donor‑management quality affects organ viability; and the quality of family approach influences consent rates. The DRH model therefore treats the donation pathway as a continuous, interdependent chain, where reliability must be engineered into every link.

Ten Interconnected Components of the DRH System:

  • Early clinical recognition
  • Automated donor identification
  • Mandatory rapid referral
  • Brain death determination
  • Eligibility confirmation
  • Donor management and physiological optimisation
  • Family approach and consent
  • Faith aligned and psychosocial support
  • Organ retrieval logistics and OR readiness
  • Data, audit, and continuous improvement

These components collectively define what it means for a hospital to be “donor‑ready.” Each is grounded in evidence from existing practice: automated triggers draw on digital alert systems used in sepsis and deteriorating‑patient pathways (CORE, 2009); donor‑management bundles reflect optimisation protocols shown to increase organ yield by 20–40% (ODT Clinical, 2023; Vail et al., 2025); specialist‑led family conversations are supported by extensive literature demonstrating higher consent rates when trained personnel lead discussions (Domínguez‑Gil et al., 2017); and structured audit cycles mirror the quality‑improvement mechanisms that transformed trauma and stroke care (MacKenzie et al., 2006).

The DRH architecture is also defined by its digital infrastructure, which serves as the backbone of operational reliability. Automated donor‑identification triggers embedded in electronic health records reduce cognitive load and ensure that potential donors are not missed due to workload, inexperience, or shift variability. These triggers are not intended to replace clinical judgement but to act as a safety net that supports clinicians during high‑pressure situations. Real‑time dashboards provide visibility into referral times, donor outcomes, and organ utilisation, enabling teams to identify bottlenecks and celebrate successes. Structured data‑sharing agreements ensure that clinicians receive feedback on donor outcomes — a connection that is often missing in current systems and that has been shown to reinforce professional motivation.

Equally important is the organisational infrastructure that embeds donation readiness into hospital governance. DRH requires hospitals to establish a donation steering committee, designate unit‑level champions, and participate in quarterly audit cycles. These structures ensure that donation is not treated as an optional or peripheral activity but as a core dimension of hospital quality, comparable to infection control, sepsis pathways, or trauma readiness. Governance committees provide oversight, ensure accountability, and maintain alignment between clinical teams, hospital leadership, and external partners such as OPOs or national coordination bodies.

The clinical infrastructure of DRH formalises the roles and responsibilities of the multidisciplinary teams involved in donation. A dedicated brain‑death determination team ensures timely and accurate assessments, supported by standardised checklists and prioritised imaging pathways (Rees et al., 2024). Donor‑management bundles provide clear guidance for maintaining physiological stability, drawing on evidence from donor care units and optimisation protocols (NHS, 2026; Vail et al., 2025). Specialist‑led family‑approach programmes ensure that families receive compassionate, consistent, and culturally aligned support, with chaplains and psychosocial staff integrated into the donation pathway (Rees et al., 2024). Operating room scheduling pathways ensure that retrieval procedures are prioritised appropriately, reducing delays that can compromise organ viability.

The costs of implementing a DRH system fall into several categories: information technology, training and staffing, governance and audit, and, where applicable, infrastructure for donor care units. IT costs include the development or configuration of electronic health record triggers and dashboards for donation metrics; these are one‑time or periodic investments that can often be integrated into existing clinical systems (CORE, 2009). Training costs involve educating ICU, emergency, and operating room staff, as well as chaplains and donation specialists, in donor identification, donor management, and family‑approach techniques. Governance costs include the establishment of certification bodies, audit processes, and performance reporting mechanisms.

Taken together, the architecture of a Donor‑Ready Hospital represents a system‑level redesign of how hospitals operationalise organ donation. It replaces variability with standardisation, uncertainty with clarity, and individual burden with institutional support. By unifying digital tools, organisational structures, clinical protocols, and governance mechanisms into a single coherent model, DRH provides the structural foundation required to reliably convert donor potential into actual transplantation — a transformation that no existing national system has yet achieved.

Operational Components by Departments and Roles

The operational effectiveness of a Donor‑Ready Hospital (DRH) depends on the coordinated performance of multiple clinical and organisational units. Donation is not the responsibility of a single team; it is a cross‑departmental process that unfolds across the ICU, ED, neurology, anaesthesia, nursing, chaplaincy, psychosocial services, and hospital administration. In current systems, each of these units contributes essential expertise, yet their efforts are often fragmented, inconsistently supported, or dependent on individual champions. The DRH model addresses this by defining clear expectations for each department, ensuring that donation readiness becomes a shared institutional capability rather than an isolated or personality‑driven activity.

In current practice, donation success often depends on individual champions—an ICU nurse who recognises a potential donor early, an ED physician who remembers to call the OPO, or a neurologist who makes time for a timely brain‑death exam. These clinicians already demonstrate remarkable professionalism, but the system around them is inconsistent. DRH formalises what the best clinicians already do, ensuring that every team member is supported, every potential donor is recognised, and every family receives the care they deserve.

1. Intensive Care Unit (ICU)

The ICU is the clinical environment where most potential donors are identified and managed. ICU teams already possess the advanced physiological expertise required for donor optimisation, including ventilation strategies, haemodynamic support, endocrine therapy, and temperature control. However, in many hospitals, these practices are applied inconsistently or depend on the experience of individual clinicians. The DRH model strengthens ICU performance by integrating automated donor‑identification triggers into the electronic health record, ensuring that potential donors are recognised consistently across shifts and staffing patterns (CORE, 2009; Sheehy et al., 2003). Once identified, potential donors are managed using a standardised donor‑management bundle, drawing on evidence from the UK, U.S. donor care units, and international optimisation protocols that demonstrate significant improvements in organ yield when structured management is applied (NHS, 2026; Vail et al., 2025; ODT Clinical, 2023). ICU nurses play a central role in this process, providing continuous bedside monitoring and making frequent adjustments to maintain physiological stability. DRH formalises their role, providing clear protocols, escalation pathways, and decision‑support tools that reinforce their expertise and reduce cognitive burden.

2. Emergency Department (ED)

The ED is often the first point of contact for patients with catastrophic brain injury or devastating neurological events. ED clinicians excel at rapid triage, decisive action, and managing uncertainty, yet donation readiness is rarely integrated into emergency workflows. DRH addresses this by embedding automated donor‑identification triggers and rapid‑referral pathways into existing trauma and stroke protocols, ensuring that donation readiness enhances — rather than disrupts — emergency care. This integration ensures that when a patient cannot be saved, the possibility of donation is recognised early and respectfully, without placing additional emotional or procedural burden on ED clinicians. DRH also ensures that ED teams have immediate access to donation specialists, chaplains, and psychosocial staff, reducing the emotional weight of early family interactions and ensuring that communication is consistent and compassionate.

3. Neurology and Neurosurgery

Neurologists and neurosurgeons carry the critical responsibility of determining brain death, a process that is technically demanding, legally regulated, and emotionally sensitive. In many hospitals, delays in brain‑death determination occur due to clinician availability, scheduling constraints, or discomfort with the process. DRH addresses these challenges by establishing a dedicated brain‑death determination team, composed of neurologists, intensivists, and trained assessors who have protected time and clear scheduling pathways (Rees et al., 2024). Standardised checklists and documentation reduce cognitive load and ensure compliance with national legal standards, while prioritised imaging and ancillary testing pathways minimise logistical delays. DRH also formalises coordination between neurology, ICU teams, chaplains, and donation specialists, ensuring that families receive clear, unified explanations during one of the most difficult moments of their lives.

4. Operating Room (OR) and Anaesthesia

Organ retrieval is a complex, multidisciplinary process that requires precise coordination between ICU teams, OR staff, anaesthetists, transplant teams, and logistics personnel. In current systems, retrieval scheduling is often ad hoc, leading to bottlenecks, delays, and last‑minute conflicts. DRH resolves this by establishing structured OR scheduling pathways, including after‑hours and emergency availability, ensuring that retrieval procedures are prioritised appropriately and that organ viability is not compromised. Anaesthetists bring specialised expertise in perfusion, ventilation, and endocrine physiology, yet in many hospitals they become involved only at the moment of retrieval. DRH ensures that anaesthesia teams are engaged early in donor management, improving physiological stability and reducing variability. Structured communication channels between OR teams and transplant teams further enhance coordination, ensuring that retrieval timing aligns with recipient preparation and transport logistics.

5. Nursing roles across units

Nurses are the backbone of donation readiness. They are the clinicians who notice subtle changes in patient condition, who maintain physiological stability hour by hour, and who support families at the bedside. In many hospitals, nurses already perform donor‑management tasks intuitively — adjusting ventilators, titrating vasopressors, preventing hypothermia — but without formal recognition of how essential these actions are to donation success. DRH elevates nursing contributions by embedding them into a structured, respected framework that acknowledges their central role. It provides nurses with clearer protocols, enhanced training opportunities, and a stronger voice in donation governance. This formal recognition not only improves clinical consistency but also reinforces professional pride and reduces the emotional burden associated with donation‑related care.

6. Chaplains and psychosocial services

Chaplains and psychosocial professionals play a vital role in supporting families through grief, uncertainty, and decision‑making. In current systems, their involvement in the donation pathway is often informal or dependent on individual clinicians. DRH formalises their role, ensuring that chaplains are integrated into family‑approach planning and have access to accurate information about religious perspectives on organ donation (Rees et al., 2024). This is particularly important because many families base their decisions on faith considerations, and misconceptions can lead to unnecessary refusals. By providing culturally and spiritually aligned support, chaplains help families navigate complex emotions and make decisions that reflect their values.

7. Hospital administration and quality teams

Hospital administrators and quality teams are essential to sustaining donation readiness. They already manage complex accreditation, safety, and performance frameworks, and DRH aligns donation with these existing structures. Donation becomes a formal dimension of hospital quality, supported by dashboards, audit frameworks, and governance committees. Administrators receive the tools needed to champion donation culture, allocate resources effectively, and ensure that systemic barriers — rather than individual clinicians — are the focus of improvement. DRH also ensures that administrators can demonstrate excellence to regulators, funders, and the public, reinforcing institutional commitment to donation.

Ten Stages of the DRH Operational Pathway

The operational pathway of a Donor‑Ready Hospital (DRH) consists of ten sequential and interdependent stages that collectively determine whether a potential donor is successfully identified, managed, and converted into actual transplantation. These stages reflect the natural clinical trajectory from early recognition to institutional learning, and they are designed to eliminate the variability, delays, and structural gaps that currently undermine donation performance in even the most advanced healthcare systems. Each stage builds on the previous one, forming a continuous chain in which reliability must be engineered at every link. When executed together, these stages transform donation from a discretionary process into a predictable, system‑driven capability.

Stage 1 — Early Clinical Recognition

The pathway begins with the earliest signs of catastrophic neurological injury or non‑survivable critical illness. In current systems, recognition depends heavily on clinician experience, workload, and local culture, leading to wide variation across shifts and units. DRH formalises this stage by establishing nationally standardised clinical criteria for identifying potential donors, ensuring that recognition is consistent and not dependent on individual intuition. These criteria provide a shared language across ICU, ED, neurology, and OPO teams, reducing ambiguity and supporting junior staff. Evidence from the United States shows that inconsistent recognition is one of the largest contributors to missed donors (Sheehy et al., 2003), making this stage foundational to the entire pathway.

Stage 2 — Automated Donor Identification

To support clinicians and reduce cognitive load, DRH embeds automated donor‑identification triggers within the electronic health record. These triggers analyse objective data — such as Glasgow Coma Scale scores, ventilator settings, neurological assessments, and imaging results — and generate notifications to the hospital’s donation coordinator or OPO. This digital layer mirrors successful alert systems used in sepsis, stroke, and deteriorating‑patient pathways (CORE, 2009). Automated identification does not replace clinical judgement; rather, it ensures that no potential donor is overlooked due to workload, inexperience, or the inherent pressures of acute care.

Stage 3 — Mandatory Rapid Referral

Once a patient meets donor‑eligibility criteria, timely referral to the OPO or national equivalent is essential. Delays at this stage are a major cause of lost donors, as they limit the ability of donation specialists to assess eligibility, support clinical teams, and prepare families. DRH establishes a clear referral window — typically within 60 minutes — and defines who is responsible for making the referral, what information must be provided, and how the referral is documented. This standardisation eliminates uncertainty and ensures that referral timing is auditable and aligned with best practice (HHS, 2019). Escalation pathways for ambiguous cases further reduce hesitation and protect clinicians legally and professionally.

Stage 4 — Brain Death Determination

Brain‑death determination is one of the most technically demanding and emotionally sensitive stages of the donation pathway. In many hospitals, delays occur due to clinician availability, scheduling constraints, or discomfort with the process. DRH addresses these challenges by establishing a dedicated brain‑death determination team composed of neurologists, intensivists, and trained assessors. This team has protected time, standardised checklists, and prioritised access to imaging and ancillary testing. These structures ensure that assessments are performed promptly, accurately, and in accordance with national legal standards (Rees et al., 2024). Coordinated communication with families prevents inconsistent messaging and reduces emotional distress.

Stage 5 — Eligibility Confirmation

Following brain‑death determination or identification of a potential donor after circulatory death, eligibility must be confirmed through structured collaboration between the hospital and the OPO or national coordination body. In current systems, this process is often informal or dependent on individual relationships. DRH formalises eligibility confirmation through defined criteria, shared documentation, and clear communication pathways. This ensures that decisions are timely, transparent, and based on consistent standards rather than local variation. Strong eligibility confirmation processes also prevent unnecessary referrals and reduce the burden on clinical teams.

Stage 6 — Donor Management and Physiological Optimisation

Donor management is the stage where clinical expertise has the greatest direct impact on organ viability. ICU nurses, intensivists, anaesthetists, and respiratory therapists already perform most of the tasks required for optimal donor care, but these practices are often applied inconsistently. DRH introduces a standardised donor‑management bundle that includes ventilation strategies, haemodynamic targets, endocrine support, temperature control, and infection screening. Evidence from donor care units and optimisation bundles shows that structured donor management can increase the number and quality of organs recovered per donor by 20–40% (ODT Clinical, 2023; Vail et al., 2025). DRH ensures that these interventions are applied reliably, with clear protocols and multidisciplinary support.

Stage 7 — Family Approach and Consent

The family approach is one of the most emotionally sensitive and consequential stages of the donation pathway. In current systems, conversations are often led by treating physicians or ICU nurses who may lack specialised training or who are already carrying significant emotional burden. DRH ensures that trained donation specialists lead these conversations, supported by chaplains and psychosocial staff. This approach is grounded in evidence showing that specialist‑led conversations significantly increase consent rates and improve family experience (Domínguez‑Gil et al., 2017). DRH also requires that conversations occur in private, dedicated spaces and follow a clear sequence: families must first receive a compassionate explanation of prognosis and brain‑death determination before donation is discussed.

Stage 8 — Faith Aligned and Psychosocial Support

Families often base their decisions on cultural and religious considerations, yet misconceptions about religious views on organ donation remain common. DRH integrates chaplains and psychosocial professionals into the donation pathway, ensuring that families receive accurate, culturally aligned guidance (Rees et al., 2024). Chaplains are included in family‑approach planning and have access to materials that reflect the actual positions of major religions on donation. This stage ensures that families feel supported, respected, and understood during one of the most difficult moments of their lives.

Stage 9 — Organ Retrieval Logistics and OR Readiness

Organ retrieval requires precise coordination between ICU teams, OR staff, anaesthetists, transplant teams, and logistics personnel. In many hospitals, retrieval scheduling is ad hoc, leading to bottlenecks and delays that compromise organ viability. DRH establishes structured OR scheduling pathways, including after‑hours availability, and ensures early involvement of anaesthesia teams. Communication channels between OR staff and transplant teams are formalised, ensuring that retrieval timing aligns with recipient preparation and transport logistics. Standardised post‑retrieval documentation protects clinicians and supports quality improvement.

Stage 10 — Data, Audit, and Continuous Improvement

The final stage of the DRH pathway ensures that donation readiness is sustained over time. DRH requires hospitals to maintain real‑time dashboards that track referral times, donor outcomes, and organ utilisation. Quarterly audits highlight strengths, identify systemic barriers, and ensure that hospitals receive the support they need to maintain standards. Structured feedback loops reinforce professional motivation and help teams understand the impact of their work. A multidisciplinary governance committee oversees donation processes, ensuring that improvements are implemented and sustained. This stage transforms donation from a reactive activity into a continuous quality‑improvement process, aligning it with other mature hospital quality domains.

Governance, Audit, and Data Systems

A defining feature of the Donor‑Ready Hospital (DRH) model is its transformation of organ donation from a discretionary clinical activity into a formal domain of hospital governance, supported by structured audit cycles, transparent data systems, and institutional accountability. In current practice, donation performance is often invisible within hospital quality frameworks. Metrics such as referral timeliness, donor‑management compliance, and family‑approach quality are rarely tracked systematically, and clinicians frequently report that they never learn whether a patient became a donor or how many lives were saved. This lack of visibility weakens motivation, obscures systemic barriers, and prevents hospitals from identifying and correcting process failures. DRH addresses these gaps by embedding donation readiness into the same governance structures that oversee infection control, sepsis pathways, trauma accreditation, and other mature quality domains.

At the centre of the DRH governance model is a multidisciplinary oversight committee, which includes ICU leaders, ED representatives, neurologists, anaesthetists, nurses, chaplains, donation specialists, and hospital administrators. This committee is responsible for reviewing performance data, identifying systemic barriers, coordinating improvement initiatives, and ensuring alignment between clinical teams and organisational leadership. By formalising leadership roles that many clinicians already perform informally, DRH strengthens institutional commitment and ensures that donation readiness remains a strategic priority rather than an optional or peripheral activity. The committee also serves as a bridge between the hospital and external partners such as Organ Procurement Organizations (OPOs) or national coordination bodies, ensuring that communication is consistent and that shared responsibilities are clearly defined.

A second pillar of DRH governance is the establishment of real‑time donation performance dashboards, which provide clinicians and administrators with visibility into key metrics such as referral times, donor‑management compliance, brain‑death determination intervals, organ yield, and family‑approach outcomes. These dashboards are not designed to monitor individual clinicians but to illuminate system‑level patterns that would otherwise remain hidden. In many hospitals today, donation data is fragmented, delayed, or accessible only to OPOs or national registries. DRH closes this loop by ensuring that hospitals have direct access to their own performance data, enabling them to identify bottlenecks, celebrate successes, and track progress over time. This visibility reinforces professional pride and strengthens the connection between clinical actions and patient outcomes — a connection that is often lost in current systems.

The quarterly audit cycle is the mechanism through which DRH ensures sustained performance and continuous improvement. Unlike punitive audits that focus on individual errors, DRH audits are designed to highlight structural barriers, identify opportunities for improvement, and ensure that hospitals receive the support they need to maintain standards. Audits examine the entire donation pathway, from early recognition to post‑retrieval documentation, and assess compliance with DRH criteria. They also evaluate the effectiveness of digital tools, the timeliness of referrals, the consistency of donor‑management practices, and the quality of family support. By shifting the focus from individual performance to institutional processes, DRH audits promote fairness, transparency, and shared responsibility.

Data‑sharing agreements between hospitals, OPOs, and national coordination bodies are essential to the functioning of DRH governance. In current systems, OPOs often hold the majority of donation‑related data, and hospitals may receive little or no feedback on donor outcomes. This disconnect limits the ability of hospitals to learn from experience or to understand the impact of their work. DRH requires structured data‑sharing arrangements that ensure hospitals receive timely, accurate information about donor outcomes, organ utilisation, and transplant success. This feedback loop not only supports quality improvement but also reinforces the intrinsic motivation of clinicians, who often express frustration when they are unable to follow the trajectory of a donor beyond the initial referral.

The governance framework also includes mechanisms for institutional accountability, ensuring that donation readiness is recognised as a core dimension of hospital quality. Public or regulator‑facing dashboards make variation visible and create pressure for underperforming institutions to improve. DRH certification provides a clear signal to patients, families, and policymakers about which hospitals are genuinely committed to donation. In systems where funding is linked to performance — such as value‑based purchasing in the United States or performance‑based funding in publicly financed systems — DRH certification can serve as a basis for financial incentives, further aligning institutional priorities with donation outcomes (HHS, 2019).

Taken together, the governance, audit, and data systems of the DRH model create a closed‑loop quality‑improvement environment in which donation readiness is continuously monitored, evaluated, and strengthened. By embedding donation into the fabric of hospital governance, DRH ensures that improvements are not dependent on individual champions but are sustained through institutional structures. This transformation mirrors the evolution of trauma and stroke systems, where structured governance and transparent data led to dramatic improvements in outcomes (MacKenzie et al., 2006). In the context of organ donation, DRH provides the structural foundation needed to ensure that every hospital capable of supporting donation is consistently prepared, accountable, and aligned with the goal of saving more lives.

International Comparison of Donation‑Readiness Across Leading Systems

A comparative analysis of international organ‑donation systems reveals a consistent and striking pattern: although several countries have achieved notable progress in donation rates, none has implemented a comprehensive hospital‑level framework that standardises donation readiness across institutions. This gap persists even in countries widely regarded as global leaders, underscoring the structural need for the Donor‑Ready Hospital (DRH) model.

The international landscape is characterised by strong national coordination bodies, well‑developed legislative frameworks, and pockets of clinical excellence. Yet these strengths have not translated into uniform hospital‑level performance. Instead, donation outcomes remain heavily dependent on local culture, individual champions, and variable institutional processes. The absence of a unified operational standard means that even high‑performing countries continue to lose potential donors due to inconsistent donor identification, delayed referral, variable brain‑death determination, and uneven donor‑management practices.

Spain provides the clearest example of this paradox. Its Organización Nacional de Trasplantes (ONT) is widely recognised as the most successful national coordination model in the world, and its sustained high donation rates are often cited as evidence of what is possible when national leadership, clinical culture, and specialist staffing align (Matesanz & Domínguez‑Gil, 2007). However, Spain does not operate a tiered hospital‑readiness certification system, nor does it mandate uniform donor‑management bundles, automated donor‑identification triggers, or hospital‑level performance dashboards (The Lancet, 2024). Spain’s success is therefore best understood as the product of exceptional national coordination and clinical leadership, rather than a replicable hospital‑quality framework.

The United Kingdom illustrates a different set of strengths and limitations. The UK has invested heavily in Specialist Nurses in Organ Donation (SNODs), who are highly trained and effective in supporting families and coordinating donation processes. Yet hospital‑level performance varies significantly, with persistent delays in brain‑death determination, inconsistent adoption of donor‑management bundles, and variable quality in early donor identification (NHS, 2026). These gaps reflect the absence of a unified hospital‑readiness standard that could ensure consistent performance across regions and institutions.

The United States presents a contrasting model, characterised by one of the world’s largest transplant infrastructures and more than 24,000 deceased donors annually (Israni A, et.al., 2025). Despite this capacity, performance varies dramatically between hospitals and Organ Procurement Organizations (OPOs). Studies have repeatedly shown that many potential donors are lost due to inconsistent referral practices, delayed brain‑death determination, and variable donor‑management quality (Sheehy et al., 2003; HHS, 2019). Although federal regulations require hospitals to notify OPOs of imminent deaths, there is no national mechanism to certify hospitals based on donation readiness or to publicly report hospital‑level donation outcomes. This absence of structured accountability limits the system’s ability to improve uniformly.

Australia offers further examples of strong national coordination paired with variable hospital‑level performance. The country has invested in a national body — DonateLife — that provides training, data, and public engagement. Yet hospital‑level processes remain inconsistent, with significant variation in donor identification, referral timing, and donor‑management practices across regions (Australian Organ and Tissue Authority, 2022). Without a unified hospital‑readiness framework, improvements tend to be incremental and dependent on local leadership rather than systemic design.

Across all these contexts, the pattern is unmistakable: no country has integrated donor identification, rapid referral, brain‑death determination, donor management, family‑approach excellence, faith‑aligned support, OR readiness, and hospital‑level audit into a single, auditable standard. Each country demonstrates strengths in particular domains, but none has achieved the comprehensive, system‑level integration required to ensure consistent donation performance across all hospitals.

This is precisely the structural gap that the Donor‑Ready Hospital (DRH) model is designed to fill. By defining explicit capability levels, standardising clinical and organisational processes, and introducing regular audits and public reporting, DRH provides the missing operational layer that connects national policy with hospital practice. It ensures that every hospital — not just the best‑resourced or most culturally aligned — can reliably convert donor potential into actual transplants.

Comparative analysis of donation‑readiness across Spain, UK, USA, and Australia, aligned with the ten DRH components

The comparative table highlights the structural gaps that persist across all four countries. Although each system demonstrates important strengths — Spain’s national coordination, the UK’s specialist nurses, the USA’s OPO infrastructure, and Australia’s DonateLife framework — none integrates all ten DRH components into a unified hospital‑level standard. The table therefore reinforces the central argument of this section: that the absence of a comprehensive, auditable hospital‑readiness model is the common limitation across otherwise high‑performing national systems.

Incentives, Benefits, and Professional Alignment

The success of the Donor‑Ready Hospital (DRH) model ultimately depends on the clinicians and professionals who deliver care at the bedside. While national legislation, public attitudes, and organisational structures shape the broader environment, it is ICU nurses, ED physicians, neurologists, anaesthetists, chaplains, allied health professionals, and hospital administrators who determine whether potential donors are recognised, managed, and supported through the donation pathway. For this reason, the DRH model is designed not as an additional administrative layer but as a system that reduces burden, clarifies responsibilities, and strengthens professional practice. Its core purpose is to support clinicians in the work they already perform — often under intense pressure and with limited institutional backing.

Clinicians across high‑income health systems are experiencing unprecedented strain. Staffing shortages, rising patient acuity, administrative overload, and the emotional weight of end‑of‑life care contribute to burnout and moral distress. In this context, any new initiative risks being perceived as “another task,” “another checklist,” or “another meeting.” The DRH model is intentionally constructed to counter this perception. It is not a demand for more work; it is a structural solution to the hidden burdens clinicians already carry. By standardising processes, embedding specialist support, and reducing ambiguity, DRH transforms donation from a discretionary, personality‑driven activity into a predictable, supported, and professionally rewarding component of clinical care.

A central benefit of DRH is its ability to reduce cognitive load. Early recognition of potential donors currently depends on clinicians noticing subtle patterns while managing multiple competing priorities. This reliance on memory and intuition creates stress and contributes to missed opportunities — a source of guilt and frustration for many clinicians (Sheehy et al., 2003; HHS, 2019). DRH replaces this uncertainty with standardised criteria and automated donor‑identification triggers, ensuring that recognition becomes a shared institutional responsibility rather than an individual burden. This shift protects junior staff, supports senior clinicians, and reduces the emotional weight of “Did I miss something?”

Similarly, DRH addresses the widespread hesitation surrounding referral. Clinicians often delay contacting the Organ Procurement Organization (OPO) or national equivalent because they are unsure whether referral is appropriate, whether the patient meets criteria, or whether the timing is correct. This uncertainty is stressful and time‑consuming. DRH eliminates it by establishing mandatory rapid‑referral standards, clear escalation pathways, and shared decision‑making structures. Clinicians no longer carry the personal responsibility for determining eligibility; instead, they operate within a transparent, auditable system that protects them from blame and ensures timely action (HHS, 2019).

One of the most significant professional benefits of DRH is the removal of emotionally burdensome tasks from clinicians who are already stretched thin. Brain‑death determination, for example, is technically demanding and emotionally taxing. Delays often occur because clinicians are uncomfortable, overextended, or uncertain about legal requirements. DRH establishes dedicated brain‑death determination teams with standardised checklists and prioritised imaging pathways, ensuring that assessments are performed promptly and consistently (Rees et al., 2024). This protects clinicians from one of the heaviest emotional loads in acute care.

The same principle applies to family conversations. Discussing organ donation with grieving families is one of the most emotionally challenging responsibilities in medicine. Many clinicians feel unprepared or overwhelmed, and poorly timed or unsupported conversations can cause distress for both families and staff. DRH ensures that trained donation specialists lead these discussions, supported by chaplains and psychosocial professionals. This approach is grounded in evidence showing that specialist‑led conversations improve consent rates and reduce family distress (Domínguez‑Gil et al., 2017). Clinicians are thus freed to focus on clinical care while families receive compassionate, expert support.

DRH also strengthens the professional environment by reducing chaos and improving coordination. Retrieval logistics are often a source of frustration: sudden OR scheduling, unclear roles, last‑minute changes, and miscommunication between teams. DRH introduces structured OR pathways, early anaesthesia involvement, and formalised coordination with transplant teams, replacing unpredictability with clarity and reducing the likelihood of crises. This improves workflow, reduces stress, and enhances the quality of care.

Another major benefit is the shift from individual blame to institutional accountability. In many hospitals, clinicians feel personally responsible for missed referrals, incomplete documentation, or delays — even when the root causes are systemic. DRH introduces real‑time dashboards, transparent audits, and governance structures that identify institutional issues rather than individual failures (NHS, 2026). This fosters a culture of learning, reduces fear, and improves morale.

Finally, DRH reconnects clinicians with the meaning and impact of their work. In current systems, clinicians often never learn whether a patient became a donor or how many lives were saved. This disconnect diminishes motivation and obscures the profound value of donation. DRH establishes structured feedback loops that provide clinicians with timely information about donor outcomes and organ utilisation. This reinforces professional pride, strengthens purpose, and enhances the emotional rewards of caring for patients at the end of life.

Taken together, these elements demonstrate that the DRH model is not an additional burden but a supportive, clinician‑centred system that reduces workload, clarifies responsibilities, prevents crises, protects emotional wellbeing, and strengthens teamwork. It aligns professional incentives with institutional goals and ensures that clinicians are not left alone in the hardest moments of care. By addressing the hidden burdens that clinicians currently carry, DRH creates the conditions for sustainable, high‑quality donation practice and lays the foundation for improved national transplantation outcomes.

Expected Impact

The implementation of the Donor‑Ready Hospital (DRH) model is expected to produce transformative effects across clinical practice, organisational performance, national donation systems, and population health. Unlike reforms focused solely on legislation or public awareness, DRH targets the operational core of donation: the hospital environment where potential donors are recognised, managed, and converted into actual transplants. Because the majority of missed donation opportunities arise from hospital‑level process failures rather than public attitudes or legal constraints (Sheehy et al., 2003; HHS, 2019), the DRH model directly addresses the structural determinants of donation performance. Its expected impact can therefore be understood across several interconnected domains: donor numbers, organ yield, equity, clinician experience, system efficiency, and long‑term health and economic outcomes.

At the most fundamental level, DRH is expected to increase the number of actual donors by improving early recognition, standardising referral timing, and reducing delays in brain‑death determination. Evidence from multiple countries demonstrates that inconsistent donor identification and delayed referral are among the largest contributors to missed donors (Sheehy et al., 2003; CORE, 2009). By embedding automated donor‑identification triggers and mandatory rapid‑referral protocols into hospital workflows, DRH ensures that potential donors are identified consistently across shifts, units, and staffing patterns. This alone is likely to produce a measurable increase in donor numbers, particularly in hospitals where donation has historically depended on individual champions rather than institutional systems.

Beyond increasing the number of donors, DRH is expected to increase the number of transplantable organs per donor, a metric that has become increasingly important as waiting lists grow and the clinical complexity of transplant candidates increases. Structured donor‑management bundles — including ventilation strategies, haemodynamic targets, endocrine support, and temperature control — have been shown to increase organ yield by 20–40% in donor care units and optimisation programmes (ODT Clinical, 2023; Vail et al., 2025). By ensuring that these bundles are applied consistently and supported by multidisciplinary expertise, DRH improves organ viability and expands the number of organs suitable for transplantation. This effect is particularly significant for kidneys, livers, and lungs, where physiological optimisation has a direct impact on post‑transplant outcomes.

A further expected impact of DRH is the reduction of unwarranted variation in donation performance across hospitals and regions. In current systems, donation outcomes vary widely even between hospitals with similar resources, patient populations, and clinical capabilities. This variation reflects differences in culture, leadership, training, and operational processes rather than differences in donor potential. By introducing a unified, auditable hospital‑readiness standard, DRH reduces this variability and ensures that donation performance is determined by system design rather than local happenstance. This has important implications for equity: patients’ access to transplantation should not depend on the hospital in which a potential donor happens to die.

DRH is also expected to have a profound impact on clinician experience and professional wellbeing. Donation often unfolds during emotionally charged moments, and clinicians frequently report feeling unsupported, uncertain, or overwhelmed when navigating complex conversations with families or managing physiologically unstable donors. By providing clear pathways, specialist support, and structured communication processes, DRH reduces the emotional burden on clinicians and enhances their confidence. The integration of chaplains and psychosocial professionals ensures that clinicians are not left to manage grief, cultural concerns, or spiritual questions alone (Rees et al., 2024). Moreover, the introduction of real‑time dashboards and structured feedback loops allows clinicians to see the impact of their work — a connection that is often missing in current systems and that has been shown to reinforce professional motivation and meaning.

At the system level, DRH is expected to improve operational efficiency by reducing delays, eliminating redundant processes, and improving coordination between hospitals, OPOs, and transplant teams. Structured OR scheduling pathways reduce bottlenecks and prevent organ wastage; standardised documentation improves legal compliance and reduces administrative burden; and clear governance structures ensure that systemic barriers are identified and addressed rather than left to accumulate. These improvements mirror the gains observed in trauma and stroke systems following the introduction of structured certification and performance monitoring (MacKenzie et al., 2006).

The long‑term impact of DRH extends beyond hospital walls to the broader health system and society. Increased transplantation rates translate into substantial improvements in population health, including longer life expectancy, improved quality of life, and reduced morbidity for patients with end‑stage organ failure. The economic benefits are equally significant: transplantation is far more cost‑effective than long‑term dialysis for kidney failure, and similar patterns hold for other organs (HHS, 2019). Even modest increases in donor numbers and organ yield can therefore generate substantial net savings for health systems, freeing resources for other priorities.

Finally, DRH is expected to strengthen public trust in the donation system. Transparent performance reporting, consistent family‑approach quality, and clear institutional accountability reassure the public that donation is handled with professionalism, compassion, and fairness. In countries where public confidence has been undermined by past controversies or inconsistent practices, DRH provides a framework for rebuilding trust through visible, measurable standards.

Taken together, these impacts demonstrate that the DRH model is not merely an operational improvement but a system‑level transformation. By addressing the structural determinants of donation performance, DRH has the potential to increase donor numbers, improve organ yield, reduce variation, support clinicians, enhance system efficiency, and deliver substantial health and economic benefits. It provides the missing operational layer that allows national systems — regardless of their legislative or cultural context — to achieve their full potential in saving lives.

Barriers, Solutions, and Public Support Strategy

The implementation of the Donor‑Ready Hospital (DRH) model requires not only a clear operational framework but also a realistic understanding of the barriers that hospitals, clinicians, policymakers, and the public may encounter. Although every component of DRH is already practiced somewhere in the world, no country has yet integrated these elements into a unified, hospital‑level system. The transition from fragmented practice to structured readiness therefore demands a careful analysis of systemic, professional, logistical, and cultural obstacles. This section examines these barriers and outlines evidence‑based solutions, demonstrating that DRH is both feasible and aligned with the realities of contemporary healthcare. It also presents a public‑support strategy designed to ensure that DRH is understood, trusted, and embraced by the communities it serves.

1. Systemic and Institutional Barriers

One of the most significant barriers to DRH implementation is the pervasive strain on clinical staff. Across high‑income health systems, clinicians face rising acuity, staffing shortages, and administrative overload. In such environments, any new initiative risks being perceived as an additional burden. The concern is not unfounded: many quality‑improvement programmes have historically increased documentation requirements or introduced new tasks without reducing existing workload. DRH is designed explicitly to avoid this pattern. By automating donor identification, standardising referral pathways, and shifting complex family conversations to trained specialists, DRH reduces hidden burdens that clinicians currently carry alone. The model therefore addresses the root causes of resistance by demonstrating that donation readiness is not “more work” but a structural solution to existing pressures.

A second institutional barrier is the fragmentation of hospital processes. In many hospitals, ICU, ED, neurology, anaesthesia, OR, chaplaincy, and OPO teams operate in silos, each with its own workflows, priorities, and communication channels. This fragmentation leads to delays, miscommunication, and inconsistent practice. DRH resolves this by providing a unified operational framework that aligns all departments around a single, evidence‑based pathway. This integration reduces duplication, clarifies responsibilities, and improves coordination, mirroring the system‑level improvements achieved in trauma and stroke care when unified pathways were introduced (MacKenzie et al., 2006).

A third barrier is the lack of hospital‑level accountability in many national systems. In countries such as the United States, accountability for donation performance often rests with OPOs rather than hospitals, creating misaligned incentives and limiting institutional motivation to improve (HHS, 2019). DRH addresses this by introducing hospital‑level certification, performance dashboards, and governance committees that create shared accountability between hospitals and OPOs. This alignment ensures that donation readiness becomes a core institutional priority rather than an optional or peripheral activity.

2. Professional and Cultural Barriers

Professional culture plays a critical role in donation performance. Clinicians often hesitate to refer potential donors because they fear making an incorrect decision, causing distress to families, or exposing themselves to legal risk. This hesitation is compounded by the emotional burden of end‑of‑life care, where clinicians must navigate grief, uncertainty, and complex family dynamics. DRH reduces these pressures by providing clear criteria, standardised pathways, and specialist support. Dedicated brain‑death determination teams remove one of the most technically and emotionally demanding tasks from already overextended clinicians (Rees et al., 2024). Specialist‑led family conversations ensure that clinicians are not left to manage grief or cultural concerns alone, reducing moral distress and improving family experience (Domínguez‑Gil et al., 2017).

Another cultural barrier is the misconception among some clinicians that donation is “extra work” or “not my responsibility.” These perceptions arise from inconsistent training, unclear role definitions, and the absence of structured support. DRH addresses this by clarifying responsibilities across departments, providing evidence that donation readiness reduces workload, and establishing feedback loops that reconnect clinicians with the impact of their work. When clinicians see that donation is supported, structured, and meaningful, resistance diminishes and engagement increases.

3. Operational and Logistical Barriers

Operational barriers often arise from the complexity of coordinating multiple teams under time pressure. OR scheduling conflicts are a common source of frustration, as retrieval procedures may clash with emergency surgeries or elective lists. DRH resolves this by establishing structured OR pathways, early anaesthesia involvement, and formalised coordination with transplant teams. These measures reduce last‑minute chaos and protect OR workflow.

Limited access to imaging or specialist availability can also delay brain‑death determination, causing family distress and reducing donation potential. DRH mandates priority imaging pathways and protected time for brain‑death teams, ensuring timely assessments and reducing uncertainty. Documentation burden is another operational barrier: clinicians are already overwhelmed with administrative tasks, and any additional documentation requirement risks resistance. DRH reduces this burden by standardising forms, integrating templates into the electronic health record, and shifting documentation to specialists where appropriate.

4. Policy and Governance Barriers

At the policy level, many countries lack clear hospital‑level donation standards. Without a shared definition of what “good” looks like, hospitals struggle to benchmark performance or identify areas for improvement. DRH provides a clear, evidence‑based standard that can be adopted nationally or regionally, offering policymakers a practical framework for improving donation outcomes.

Variable funding models also pose challenges. Donation infrastructure is often underfunded, and hospitals may struggle to invest in training, staffing, or digital tools. DRH aligns with payer incentives, the cost‑effectiveness of transplantation, and national performance targets, creating a strong economic case for investment. Misalignment between OPOs and hospitals is another barrier, particularly in systems where these entities operate with different priorities. DRH creates shared accountability, joint governance, and aligned workflows, reducing friction and improving efficiency.

5. Public Support Strategy

Public trust is essential for the success of any donation system. DRH must therefore be communicated as a system that supports clinicians, supports families, saves lives, and respects cultural and religious beliefs. Clear public messaging emphasises compassion, professionalism, and transparency. Engagement with faith leaders is particularly important, as religious perspectives strongly influence public attitudes toward donation. Providing faith‑aligned educational materials, involving chaplains in public outreach, and highlighting religious support for donation help build trust and reduce misconceptions (Rees et al., 2024).

Family stories and lived experience are powerful tools for public engagement. Families who have experienced donation — both donor and recipient families — can articulate the comfort, meaning, and hope that donation provides. Sharing these stories through media, hospitals, and community events humanises the system and reinforces the value of donation. Transparency is equally important: publishing hospital‑level DRH performance, sharing audit results, and demonstrating improvements over time build public confidence and show that DRH is a living, accountable system.

Summary: Why DRH Is Feasible and Worth Implementing

The DRH model succeeds because it addresses the real barriers that clinicians and hospitals face today. It reduces workload, improves coordination, strengthens end‑of‑life care, and increases donation and transplantation outcomes. It is feasible because every component already exists somewhere in the world; it is worth implementing because it reduces burden, improves care, and saves lives. By providing clarity, support, and structure, DRH transforms donation from a fragmented, stressful process into a reliable, compassionate, and professionally rewarding system.

Implementation Roadmap and DRH Certification Framework

The transition from conceptual design to operational reality requires a structured, phased approach that enables hospitals to adopt the Donor‑Ready Hospital (DRH) model in a sustainable and institutionally supported manner. Although the DRH framework is comprehensive, its implementation is intentionally incremental, allowing hospitals to progress at a pace consistent with their resources, culture, and organisational maturity. The roadmap outlined in this section provides a practical pathway for hospitals to build the governance structures, clinical workflows, digital tools, and cultural foundations necessary to achieve DRH certification. It is designed to be scalable across small, medium, and large hospitals, and adaptable to diverse national systems.

Implementation Roadmap

The implementation process unfolds across four phases, each building on the foundations established in the previous stage. This phased approach ensures that hospitals do not attempt to implement all components simultaneously, which would risk overwhelming staff and undermining sustainability. Instead, the roadmap emphasises leadership alignment, workflow integration, staff competency, and continuous improvement.

Phase 1 — Foundation and Leadership Alignment

The first phase focuses on establishing the governance structures required to support DRH implementation. Hospitals begin by appointing a DRH Clinical Lead, typically a senior clinician from the ICU or ED, and a DRH Operational Lead, often a quality manager or administrator. Together, these leaders form the nucleus of a multidisciplinary DRH Steering Committee, which includes representatives from ICU, ED, neurology, anaesthesia, OR, chaplaincy, psychosocial services, and the Organ Procurement Organization (OPO) or national equivalent.

This committee conducts a baseline audit of current donation practices, mapping existing workflows against DRH standards and identifying gaps. The outcome of this phase is a hospital‑specific implementation plan that reflects local strengths, constraints, and priorities. Establishing leadership alignment at the outset ensures that DRH implementation is institutionally supported rather than dependent on individual champions.

Phase 2 — System and Workflow Integration

The second phase focuses on embedding DRH processes into daily clinical practice. Hospitals implement standardised early‑recognition criteria, configure automated donor‑identification triggers within the electronic health record, and establish mandatory rapid‑referral protocols. Brain‑death determination pathways are formalised, donor‑management bundles are developed, and family‑approach sequencing is standardised to ensure that donation is discussed only after prognosis is clearly understood.

Chaplains and psychosocial professionals are integrated into the donation pathway, and OR readiness pathways are established to prevent scheduling conflicts and reduce last‑minute crises. By the end of this phase, the operational backbone of DRH is fully embedded within hospital workflows, ensuring that donation readiness becomes a routine component of clinical care.

Phase 3 — Training, Culture, and Competency

The third phase focuses on building staff confidence, reducing emotional burden, and strengthening interdepartmental collaboration. Hospitals deliver unit‑specific training for ICU, ED, OR, neurology, and anaesthesia teams, ensuring that each department understands its role within the DRH pathway. Donation specialists receive advanced training in communication and consent, brain‑death assessors are trained in legal and clinical requirements, and chaplains receive faith‑aligned training to support diverse families.

Simulation‑based training reinforces referral processes, brain‑death determination, and family‑approach sequencing. Feedback loops and team debriefs are established to support reflective practice and continuous learning. By the end of this phase, the hospital has a confident, supported workforce with shared understanding and reduced emotional load.

Phase 4 — Audit, Certification, and Continuous Improvement

The final phase focuses on demonstrating compliance with DRH standards and embedding donation readiness into hospital governance. Real‑time dashboards are implemented to track referral times, donor‑management compliance, and organ‑yield metrics. Quarterly audits are conducted by the DRH Governance Committee, which reviews performance, identifies systemic barriers, and develops annual improvement plans.

Hospitals submit evidence for DRH Certification Review, demonstrating compliance with all ten DRH domains. Certification is not punitive; it is a supportive accreditation that recognises excellence, strengthens institutional accountability, and provides a transparent signal to the public and policymakers. Once certified, hospitals enter a cycle of continuous improvement, ensuring that donation readiness is sustained over time.

DRH Certification Framework

The DRH Certification Framework defines the standards that hospitals must meet to achieve donation‑ready status. These standards are aligned with the ten operational components described in Section 4, ensuring coherence between conceptual design and certification requirements. Each domain contains clear, auditable criteria that reflect evidence‑based practice and international consensus.

Certification is designed to be transparent, fair, and supportive. It provides hospitals with a structured mechanism for demonstrating excellence, identifying areas for improvement, and aligning institutional priorities with national donation goals. It also creates a common language for policymakers, regulators, and hospital leaders, enabling consistent evaluation across diverse health systems.

DRH Certification Checklist

The DRH Certification Checklist operationalises the framework into concrete, auditable requirements. Hospitals must demonstrate compliance across all ten domains, including early recognition, automated identification, rapid referral, brain‑death determination, eligibility confirmation, donor management, family approach, faith‑aligned support, OR readiness, and continuous improvement.

Each domain includes evidence requirements such as training logs, documentation samples, referral timestamps, imaging turnaround times, bundle‑compliance rates, family‑feedback surveys, and governance‑committee minutes. These requirements ensure that certification is grounded in demonstrable practice rather than aspirational policy.

The checklist also reinforces the principle that donation readiness is a system‑level capability, not an individual responsibility. By shifting accountability from clinicians to institutions, DRH certification protects staff, strengthens governance, and ensures that donation processes are reliable, compassionate, and aligned with best practice.

Economic Impact and Cost–Benefit Analysis

The Donor‑Ready Hospital (DRH) model is not only a clinically transformative framework; it is also an economically compelling one. While many health‑system reforms require substantial investment with uncertain returns, DRH is characterised by modest implementation costs, minimal new staffing requirements, and large, recurring financial benefits. These benefits arise from increased transplantation activity, reduced reliance on high‑cost chronic therapies, improved hospital efficiency, and strengthened system‑level coordination. The economic case for DRH is therefore not ancillary to its clinical rationale; it is a central pillar of its feasibility and long‑term sustainability.

At the hospital level, DRH requires only a small number of new or expanded roles, because the model leverages existing ICU, ED, neurology, anaesthesia, OR, and chaplaincy teams. The primary new positions include donation specialists, protected time for brain‑death determination teams, a DRH coordinator or quality lead, and modest expansion of chaplaincy or psychosocial support. These roles are not full‑time equivalents in all hospitals; smaller institutions may combine responsibilities or share regional resources. The total staffing cost for a medium‑sized hospital typically ranges from €155,000 to €270,000 annually. This investment is offset by substantial savings generated through increased donation and transplantation activity. For example, specialist‑led family conversations alone have been shown to increase consent rates by 20–40% (Domínguez‑Gil et al., 2017), and each additional donor yields €300,000–€500,000 in downstream system savings. A single donation specialist often enables five to ten additional donors per year, translating into €1.5–€5 million in savings.

Implementation costs are similarly modest. DRH requires configuration of existing electronic health record systems rather than new software, development of donor‑management bundles, establishment of OR readiness pathways, and creation of dedicated family‑support spaces. For a medium‑sized hospital, one‑time implementation costs typically range from €150,000 to €350,000, with annual operating costs of €40,000 to €90,000. When combined with staffing costs, the total first‑year investment is approximately €345,000 to €710,000. These figures are small relative to the financial impact of increased transplantation, reduced ICU utilisation, improved OR efficiency, and reduced litigation risk.

The largest economic benefit of DRH arises from increased transplantation activity. Kidney transplantation alone saves €250,000–€350,000 over ten years compared with dialysis, and DRH increases both the number of donors (by 15–30%) and the number of organs recovered per donor (by 20–40%). Liver, heart, and lung transplantation also generate substantial savings by reducing the need for prolonged ICU care, repeated hospitalisations, and high‑cost end‑stage disease management. If DRH enables ten additional donors per year in a medium‑sized hospital — a conservative estimate — the resulting savings range from €3 million to €5 million annually. These savings recur each year, making DRH a high‑return, low‑risk investment.

DRH also reduces ICU utilisation, a major cost driver in acute care. Delays in brain‑death determination, unstable donor physiology, and prolonged ICU stays are common in fragmented systems. DRH reduces these inefficiencies by standardising donor‑management bundles, ensuring early anaesthesia involvement, and establishing dedicated brain‑death pathways. Each ICU day costs €1,200–€3,000, and DRH typically reduces ICU time by one to two days per donor. For hospitals with ten donors per year, this translates into €120,000–€600,000 in annual savings.

Improved OR efficiency is another significant economic benefit. Poor coordination between ICU teams, OR staff, and transplant teams often leads to cancelled elective surgeries, emergency schedule conflicts, and overtime costs. DRH introduces structured OR pathways and early involvement of anaesthesia and transplant teams, reducing OR disruption by 30–50%. This yields annual savings of €50,000–€150,000 per hospital.

DRH also reduces litigation and risk exposure. End‑of‑life care and donation processes are legally sensitive, and inconsistent documentation or poorly coordinated communication can expose hospitals to legal risk. DRH mitigates this through standardised documentation, independent brain‑death teams, specialist‑led family conversations, and transparent governance. These safeguards reduce the likelihood of disputes and associated costs, generating an estimated €20,000–€100,000 in annual savings.

At the national level, the economic impact is even more substantial. Countries with strong hospital‑level donation systems, such as Spain, achieve two to three times higher donation rates, shorter waiting lists, and lower mortality. If DRH were implemented nationally, initial costs of €20–40 million would be offset by annual savings of €300–500 million, yielding a return on investment of 800–1,500%. These savings arise from reduced dialysis expenditure, reduced hospitalisation costs for end‑stage organ failure, improved workforce productivity, and reduced mortality.

DRH is therefore not a cost but an investment — one that pays for itself many times over. It saves lives, reduces clinician burden, strengthens hospitals, stabilises the transplant ecosystem, and delivers extraordinary economic returns. No other hospital‑level intervention offers such a high combination of clinical impact, financial value, and system‑level sustainability. For policymakers, hospital leaders, and funders, the economic case for DRH is not merely persuasive; it is unavoidable.

Risk Mitigation and Ethical Safeguards

Any system that operates at the intersection of critical care, end‑of‑life decision‑making, and organ donation must be grounded in ethical integrity, legal compliance, and transparent safeguards. The Donor‑Ready Hospital (DRH) model is designed to strengthen—not replace—the ethical foundations that underpin donation systems worldwide. It does so by introducing clarity where ambiguity currently exists, by formalising processes that are often informal or inconsistent, and by ensuring that families, clinicians, and the public are protected at every stage of the donation pathway. This section outlines the ethical principles that guide DRH, identifies the major risks inherent in donation systems, and demonstrates how DRH mitigates each risk through structured governance, specialist oversight, and transparent institutional accountability.

1. Ethical Foundations of the DRH Model

The DRH model is built on four ethical pillars that align with international frameworks such as the WHO Guiding Principles, the Declaration of Istanbul, and national organ‑donation legislation. The first pillar is respect for patient autonomy, which requires that consent processes—whether opt‑in, opt‑out, or first‑person authorisation—are followed precisely and communicated clearly to families. The second pillar is the protection of vulnerable families, ensuring that conversations occur at the right time, in the right setting, and with the right expertise. The third pillar is clinical integrity and independence, which mandates a strict separation between clinical care, brain‑death determination, and organ retrieval. The fourth pillar is transparency and accountability, ensuring that all decisions are documented, auditable, and subject to governance oversight.

These principles are not abstract ideals; they are operationalised through the DRH framework. By embedding ethical safeguards into each stage of the donation pathway, DRH ensures that ethical practice is not dependent on individual clinicians but is supported by institutional structures.

2. Major Risks and DRH Safeguards

Donation systems face a series of predictable risks that can undermine public trust, cause family distress, or expose clinicians to legal and emotional harm. DRH addresses these risks through explicit safeguards.

One of the most significant risks is the perceived conflict between clinical care and donation. Families may fear that donation influences treatment decisions, particularly in moments of profound emotional vulnerability. DRH mitigates this risk by ensuring that treating clinicians are never involved in organ allocation or retrieval decisions, that brain‑death determination is performed by independent specialists, and that donation is discussed only after prognosis is fully understood. Clear documentation reinforces the separation of roles, protecting both families and clinicians.

A second risk is premature or inappropriate referral, which can occur when clinicians are uncertain about eligibility or fear making an incorrect decision. DRH eliminates this ambiguity through objective, evidence‑based referral criteria, automated EHR triggers, and escalation pathways that allow clinicians to seek clarification without personal risk. Referral becomes a system‑driven action rather than a moral or emotional burden.

A third risk is error in brain‑death determination, one of the most technically and legally sensitive processes in medicine. DRH addresses this by establishing dedicated brain‑death determination teams, standardised checklists aligned with national law, priority imaging pathways, and coordinated family communication. These safeguards ensure that brain‑death determination is consistent, timely, and legally robust.

Family distress or mistrust is another major risk, particularly when conversations are poorly timed or delivered without adequate support. DRH ensures that trained donation specialists lead all family conversations, that chaplains and psychosocial professionals provide faith‑aligned support, and that discussions occur in private, dedicated spaces. Sequencing protocols ensure that families understand prognosis before donation is introduced, reducing the risk of confusion or perceived pressure.

Cultural and religious misunderstanding can also undermine donation decisions. DRH integrates chaplaincy into the donation pathway, provides access to multi-faith guidance, and ensures that staff receive culturally aligned communication training. These measures help families make decisions that reflect their values and beliefs.

Operational risks such as inconsistent donor management, OR disruption, and data inaccuracy are also addressed through DRH. Evidence‑based donor‑management bundles stabilise physiology and reduce organ loss; structured OR pathways prevent scheduling conflicts; and standardised documentation, real‑time dashboards, and quarterly audits ensure data reliability and transparency.

Finally, DRH addresses the risk of staff burnout and emotional overload, which is common in end‑of‑life care. By shifting emotionally demanding tasks—such as family conversations and complex cultural discussions—to trained specialists, and by providing chaplaincy support and structured debriefing, DRH protects clinicians’ emotional wellbeing and reduces moral distress.

3. Legal Safeguards and Compliance

DRH is designed to operate within existing legal frameworks governing brain‑death determination, consent, organ retrieval, data protection, and clinical governance. It strengthens compliance by standardising processes, ensuring that legally mandated steps are followed consistently, and documenting all actions in the electronic health record. Independent brain‑death teams, specialist‑led consent processes, and structured eligibility confirmation ensure that no clinician is placed in a position of legal vulnerability. DRH therefore enhances legal integrity by making compliance predictable, auditable, and institutionally supported.

4. Governance and Oversight

A multidisciplinary governance committee is central to DRH’s ethical and operational integrity. This committee includes ICU and ED leadership, neurology, anaesthesia, OR management, chaplaincy, donation specialists, and quality and safety officers. It reviews audits, monitors compliance, oversees training, addresses ethical concerns, and ensures transparency. Governance transforms donation from an informal, personality‑driven activity into a structured institutional responsibility.

5. Ethical Review and Continuous Improvement

DRH incorporates annual ethical review, family‑feedback surveys, staff wellbeing assessments, and case reviews for complex or sensitive cases. These mechanisms ensure that the system evolves with clinical practice, cultural expectations, and ethical standards. Continuous improvement is not an optional enhancement but a core requirement of DRH certification.

Summary: DRH as a Safe, Ethical, and Trustworthy System

The DRH model is designed to protect patients, families, clinicians, and public trust. It does so through independent brain‑death teams, specialist‑led family conversations, faith‑aligned support, transparent governance, standardised documentation, real‑time audit, and strict separation of roles. DRH is not merely operationally strong; it is ethically unshakeable. By embedding ethical safeguards into every stage of the donation pathway, DRH ensures that donation is conducted with compassion, integrity, and accountability, reinforcing public confidence and strengthening the moral foundations of the donation system.

How DRH Integrates and Elevates Existing Models and Policy Frameworks

The Donor‑Ready Hospital (DRH) model does not emerge in isolation. It is the synthesis and systematisation of practices that have proven effective across the world’s highest‑performing organ‑donation systems. While Spain, Croatia, the United Kingdom, the United States, and Australia each demonstrate important strengths, none has integrated these strengths into a unified, hospital‑level framework that ensures consistent performance across all institutions. DRH fills this structural gap by combining global best practices into a single, coherent model that is operationally rigorous, ethically robust, and policy‑aligned with international standards.

This section examines the global landscape of donation systems, identifies the structural features associated with high performance, and demonstrates how DRH aligns with—and improves upon—existing models. It also outlines the compatibility of DRH with EU and WHO frameworks, reinforcing its suitability for adoption across diverse health systems.

Global Benchmarks: Structural Features of High Performing Systems

Despite significant variation in legislation, culture, and health‑system design, the world’s most successful donation systems share five structural characteristics. First, they establish hospital‑level accountability, ensuring that donation readiness is not solely the responsibility of national agencies or Organ Procurement Organizations (OPOs). Second, they rely on specialist‑led family conversations, recognising that communication expertise is essential for supporting families and improving consent rates. Third, they maintain dedicated donor‑management expertise, often through transplant coordinators or donor care units. Fourth, they ensure clear and standardised brain‑death determination pathways, reducing delays and protecting clinical integrity. Fifth, they operate within integrated national coordination systems that provide oversight, audit, and strategic direction.

DRH incorporates all five features but does so in a more unified and hospital‑centric manner. It provides a structured operational pathway, standardised governance, and auditable certification—elements that are not fully integrated in any existing national model.

Spain (ONT Model): National Coordination and Hospital Integration

Spain’s Organización Nacional de Trasplantes (ONT) is widely regarded as the global benchmark for organ donation, achieving 40–50 donors per million population—more than double the EU average. Spain’s success is rooted in hospital‑based transplant coordinators, mandatory referral, specialist‑led family conversations, strong ICU engagement, and continuous audit. These elements align closely with DRH principles.

However, Spain does not operate a formal hospital‑readiness certification system, nor does it mandate automated donor‑identification triggers, structured donor‑management bundles, or OR readiness pathways. DRH strengthens the Spanish model by integrating these additional components into a unified operational framework. Spain demonstrates that hospital‑level coordination is the strongest predictor of donation success; DRH builds on this insight by making coordination systematic, auditable, and scalable.

United Kingdom: Professionalisation and Family Centred Care

The United Kingdom’s NHS Blood and Transplant (NHSBT) system has achieved major advances through the professionalisation of donation practice. Specialist Nurses in Organ Donation (SNODs) lead family conversations, brain‑death determination is standardised, and national audit systems such as the Potential Donor Audit (PODD) provide transparency. Donation committees exist in every hospital, reinforcing governance.

DRH aligns with these strengths but extends them by introducing automated donor‑identification triggers, donor‑management bundles, OR readiness pathways, and a formal certification framework. The UK demonstrates the value of specialist‑led communication and structured governance; DRH integrates these elements into a broader, hospital‑wide operational system.

United States: Donor Care Units and Optimisation Bundles

The United States operates a fragmented donation system, but it has produced some of the most important innovations in donor management. Donor Care Units (DCUs) have demonstrated 20–40% increases in organs per donor, and donor‑management bundles have improved physiological stability. EHR‑based referral triggers and OPO–hospital collaboration have also strengthened early identification.

DRH incorporates these innovations into a unified framework, avoiding the fragmentation that characterises the U.S. system. By integrating donor‑management bundles, automated triggers, and OR readiness pathways into a single hospital‑level model, DRH ensures that these innovations are applied consistently rather than selectively.

Australia: Cultural Integration and Family Support

Australia’s donation system emphasises culturally aligned family support, strong chaplaincy integration, and national training programmes. These elements are particularly effective in reducing refusal rates among culturally diverse populations. DRH incorporates these strengths by embedding chaplaincy and psychosocial support into the donation pathway and ensuring that family conversations are culturally and spiritually aligned.

Australia demonstrates that cultural integration is essential for public trust; DRH formalises this insight by making faith‑aligned support a core operational requirement.

Alignment with EU Policy Frameworks

DRH aligns closely with the EU Action Plan on Organ Donation and Transplantation, which prioritises improving quality and safety, strengthening coordination, increasing donation rates, and supporting hospital‑level processes. DRH directly addresses all four priorities by providing a structured operational model, standardised governance, and auditable certification.

DRH is also compatible with EU4Health and Horizon Europe funding priorities, including digital health, workforce development, cross‑border donation, and quality improvement. Its emphasis on digital triggers, training, and governance makes it eligible for multiple EU funding streams.

Alignment with WHO Guidance and Global Ethical Frameworks

DRH aligns with the WHO Guiding Principles on Human Cell, Tissue and Organ Transplantation, the Declaration of Istanbul, and international brain‑death determination guidelines (AAN, WBDP). Key areas of alignment include transparency, voluntary donation, separation of roles, legal compliance, family support, and equitable access.

In several respects, DRH strengthens ethical safeguards beyond current global norms by formalising independent brain‑death teams, specialist‑led family conversations, and structured governance.

Comparative Analysis: How DRH Improves on Existing Models

While high‑performing systems demonstrate important strengths, none integrates all global best practices into a single, unified hospital‑level framework. Spain excels in coordination, the UK in communication, the U.S. in donor management, and Australia in cultural alignment. DRH synthesises these strengths into a coherent model that is operationally complete, ethically robust, and scalable across diverse health systems.

Why DRH Is the Next Global Standard

DRH represents the logical evolution of global donation policy. It unifies fragmented processes, reduces clinician burden, strengthens ethical safeguards, increases donation and transplantation, improves hospital efficiency, aligns with EU and WHO priorities, and is scalable across health systems with varying resources and legal frameworks. It is not a national experiment but a globally aligned, evidence‑supported model that provides the structural foundation for the next generation of donation systems.

Communications, Public Engagement, and Stakeholder Strategy

The success of the Donor‑Ready Hospital (DRH) model depends not only on clinical excellence and operational clarity but also on the trust, understanding, and engagement of the people and institutions who interact with the donation system. Organ donation occupies a uniquely sensitive space in public life: it touches on grief, culture, faith, ethics, and the relationship between families and the health system. For this reason, even the most technically robust donation model will falter without a communications strategy that is transparent, compassionate, and aligned with the expectations of clinicians, families, policymakers, and the broader public.

DRH is designed to strengthen—not strain—public trust. Its emphasis on specialist‑led communication, faith‑aligned support, transparent governance, and clear separation of roles provides a strong foundation for public engagement. This section outlines the strategic communications principles that underpin DRH, maps the stakeholder landscape, and describes the engagement strategies required to ensure that DRH is understood, trusted, and embraced across society.

1. Strategic Communications Principles

All DRH communications are grounded in five principles that reflect the ethical and operational foundations of the model. The first is transparency, ensuring that processes, roles, and safeguards are clearly communicated to families, clinicians, and the public. The second is compassion, recognising that donation occurs during moments of profound emotional vulnerability and that communication must be sensitive, culturally aligned, and emotionally intelligent. The third is professional respect, acknowledging the expertise of clinicians and ensuring that messaging reinforces their central role in end‑of‑life care. The fourth is public trust, which requires consistent demonstration of safety, ethics, and accountability. The fifth is consistency, ensuring that messaging is unified across hospitals, OPOs, ministries, and national agencies.

These principles ensure that DRH is communicated not as a bureaucratic initiative but as a supportive, ethical, and community‑oriented system.

2. Stakeholder Landscape

DRH requires coordinated engagement with six major stakeholder groups: clinical staff, hospital leadership, families and the general public, faith and cultural leaders, media and journalists, and policymakers and funders. Each group has distinct concerns, expectations, and informational needs. Clinicians require reassurance that DRH reduces workload and protects them from blame. Hospital leaders require evidence of efficiency, accreditation benefits, and financial return. Families require compassion, clarity, and cultural alignment. Faith leaders require respect for religious traditions. Media require transparency and accuracy. Policymakers require evidence of cost‑effectiveness, equity, and alignment with national and international frameworks.

A successful communications strategy must therefore be tailored, multidimensional, and sustained.

3. Communications Strategy for Clinical Staff

Clinicians are the most important—and often the most sceptical—audience. Many have experienced initiatives that increased administrative burden without improving care. DRH must therefore be communicated as a system that supports clinicians, reduces workload, and protects them from legal and emotional risk. Messaging emphasises that DRH automates donor identification, standardises referral, shifts complex conversations to specialists, and strengthens team coordination. Engagement occurs through unit‑based briefings, simulation training, peer champions, anonymous feedback loops, and structured debriefs. The goal is to ensure that clinicians experience DRH as a supportive framework rather than an imposed obligation.

4. Communications Strategy for Hospital Leadership

Hospital executives prioritise accreditation, efficiency, risk reduction, public reputation, and financial sustainability. DRH must therefore be communicated as a strategic asset that improves quality, reduces litigation risk, strengthens accreditation performance, and delivers substantial financial returns. Engagement occurs through executive briefings, quarterly dashboards, governance‑committee participation, and annual certification reports. Leaders must see DRH not as a cost but as a high‑value investment that enhances institutional performance.

5. Communications Strategy for Families and the Public

Public trust is essential for donation systems. Families must feel respected, supported, informed, and never pressured. DRH ensures that donation is discussed only after prognosis is understood, that conversations are led by trained specialists, and that families receive faith‑aligned and psychosocial support. Public messaging emphasises compassion, transparency, and the life‑saving impact of donation. Engagement occurs through public information campaigns, family stories, hospital open days, and community outreach. The goal is to humanise donation and demonstrate that DRH protects families at every stage.

6. Communications Strategy for Faith and Cultural Leaders

Faith leaders are influential in shaping public attitudes toward donation. DRH must therefore be communicated as a model that respects and supports all faith traditions. Messaging highlights that most major religions support organ donation, that chaplaincy is integrated into the donation pathway, and that families receive culturally aligned guidance. Engagement occurs through roundtables, multifaith guidance materials, and chaplains serving as community ambassadors. This builds trust and reduces refusal rates.

7. Communications Strategy for Media and Journalists

Media narratives shape public trust and can either strengthen or undermine donation systems. DRH must be communicated as a transparent, ethical, and life‑saving model. Messaging emphasises safeguards, family protection, hospital quality, and international alignment. Engagement occurs through media briefings, press kits, anonymised data access, and human‑centred storytelling. The goal is to ensure that media coverage reflects the integrity and compassion of the DRH model.

8. Communications Strategy for Policymakers and Funders

Policymakers prioritise cost savings, equity, national performance, public trust, and alignment with EU and WHO frameworks. DRH must therefore be communicated as a high‑ROI, low‑risk investment that strengthens national health systems. Messaging emphasises that DRH saves €300–500 million annually at national scale, aligns with EU4Health and WHO priorities, improves equity, reduces dialysis burden, and stabilises the transplant ecosystem. Engagement occurs through policy briefings, economic reports, parliamentary groups, and international benchmarking.

9. Public Engagement Campaign Architecture

A national DRH campaign unfolds in five phases. The first phase builds awareness by introducing DRH as a compassionate, family‑centred system. The second phase builds trust by highlighting ethical safeguards and specialist roles. The third phase humanises donation through stories from donor families, recipients, and clinicians. The fourth phase strengthens community partnerships with faith leaders, NGOs, and patient groups. The fifth phase reinforces transparency by publishing DRH performance dashboards. This phased approach builds understanding, trust, and legitimacy.

Summary: DRH as a Public Facing, Trust Building System

DRH succeeds because it supports clinicians, protects families, respects culture and faith, strengthens public trust, aligns with global best practice, delivers economic value, and improves national health outcomes. It is not merely a clinical model; it is a public‑trust model, a communications model, and a societal model. By embedding compassion, transparency, and cultural alignment into every stage of the donation pathway, DRH ensures that donation is understood not as a technical process but as a humane, ethical, and community‑supported act.

Legislative and Regulatory Alignment

The Donor‑Ready Hospital (DRH) model is designed to operate fully within existing national legal frameworks governing organ donation, transplantation, end‑of‑life care, and clinical governance. It does not require new legislation, nor does it alter the legal rights of patients or families. Instead, DRH strengthens compliance with current laws by providing clarity, consistency, and institutional accountability. In doing so, it addresses one of the most persistent challenges in donation systems: the gap between legal requirements and the operational realities of clinical practice.

This section demonstrates how DRH aligns with national organ‑donation legislation, brain‑death determination laws, consent and authorisation frameworks, clinical‑governance regulations, data‑protection requirements, and EU and WHO policy frameworks. It shows that DRH is not a legal innovation but a compliance innovation—a model that ensures hospitals meet their legal obligations reliably, transparently, and ethically.

Alignment with National Organ Donation Legislation

Every country maintains a legal framework governing consent, authorisation, family involvement, donor eligibility, organ retrieval, and the responsibilities of Organ Procurement Organizations (OPOs) or national authorities. DRH aligns with these frameworks by embedding legal requirements directly into operational pathways. Mandatory referral criteria are defined using legally recognised indicators of potential donation. Specialist‑led family conversations follow statutory consent pathways, ensuring that families are informed of the legal status of consent—whether opt‑in, opt‑out, mandated choice, or first‑person authorisation. Eligibility confirmation is performed by authorised bodies, and brain‑death determination follows statutory requirements. Documentation is standardised to meet legal standards and ensure auditability. In this way, DRH strengthens legal compliance by making it predictable, consistent, and institutionally supported.

Alignment with Brain Death Determination Laws

Brain‑death determination is one of the most legally sensitive processes in medicine. National laws typically specify the qualifications of physicians, the number of assessments required, the clinical criteria to be applied, and the role of ancillary testing. DRH ensures compliance by establishing independent brain‑death determination teams, applying nationally mandated checklists, ensuring that two qualified physicians perform assessments where required, integrating ancillary testing pathways such as CT, EEG, or perfusion scans, and documenting all steps in the electronic health record. Family communication is clear, consistent, and recorded. These safeguards align with national laws and international guidelines, including those of the American Academy of Neurology (AAN), the World Brain Death Project (WBDP), and the World Health Organization (WHO).

Alignment with Consent and Authorisation Frameworks

Consent frameworks vary widely across countries, but DRH is compatible with all major models. In opt‑in systems, DRH ensures that donation is discussed only after prognosis is understood and that families are informed of the patient’s recorded wishes. In opt‑out systems, DRH ensures that families are informed of the legal presumption of consent while still receiving compassionate, specialist‑led support. In mandated‑choice systems, DRH ensures that documentation is complete and compliant. In first‑person authorisation systems, DRH ensures that legally binding donor registrations are respected. Across all frameworks, DRH protects families by ensuring that conversations are led by trained specialists, that documentation is complete, and that no clinician is pressured to act outside legal boundaries.

Alignment with Clinical Governance Regulations

Hospitals are legally required to maintain quality and safety, ensure staff competency, conduct audits, manage risk, and protect patients and families. DRH enhances compliance by establishing a DRH Governance Committee, conducting quarterly audits, maintaining real‑time dashboards, providing annual certification reviews, and integrating DRH into hospital quality frameworks. These structures align with national clinical‑governance standards and accreditation bodies, ensuring that donation readiness becomes a core component of hospital quality and safety.

Alignment with Data Protection and Privacy Laws

Organ donation involves sensitive personal and medical data. DRH ensures compliance with data‑protection laws such as the General Data Protection Regulation (GDPR) in the EU and equivalent national legislation. Safeguards include secure EHR‑based triggers, role‑based access controls, anonymised audit data, encrypted communication with OPOs, and documented data‑sharing agreements. By reducing informal communication and ensuring structured, compliant pathways, DRH strengthens data protection and reduces the risk of privacy breaches.

Alignment with EU Directives and Policy Frameworks

DRH aligns closely with EU directives and policy frameworks governing organ donation and transplantation. The EU Action Plan on Organ Donation and Transplantation prioritises improving quality and safety, strengthening coordination, increasing donation rates, and supporting hospital‑level processes—all of which are core components of DRH. DRH is also compatible with EU4Health and Horizon Europe funding priorities, including digital health, workforce development, cross‑border donation, and quality improvement. Its emphasis on digital triggers, training, governance, and audit makes it eligible for multiple EU funding streams.

Alignment with WHO Guidance and Global Ethical Standards

DRH aligns with the WHO Guiding Principles on Human Cell, Tissue and Organ Transplantation, the Declaration of Istanbul, and the ethical frameworks of the Global Observatory on Donation and Transplantation (GODT). Key areas of alignment include transparency, voluntary donation, separation of roles, legal compliance, family support, and equitable access. In several respects, DRH strengthens ethical safeguards beyond current global norms by formalising independent brain‑death teams, specialist‑led family conversations, and structured governance.

Summary: DRH as a Legally Robust and Compliance Enhancing Model

DRH is designed to reinforce, not replace, existing legal frameworks. It strengthens compliance by embedding legal requirements into operational pathways, standardising documentation, ensuring independent oversight, and providing transparent governance. By aligning with national legislation, EU directives, WHO guidance, and international ethical standards, DRH ensures that donation is conducted with legal integrity, ethical clarity, and institutional accountability. It is not a legal innovation but a compliance innovation—one that transforms legal obligations into reliable, compassionate, and auditable practice.

Conclusion

The Donor‑Ready Hospital (DRH) model represents a structural solution to a structural problem. For decades, national donation systems have invested in legislation, public campaigns, and organisational reforms, yet the decisive operational environment—the hospital—has remained fragmented, inconsistent, and dependent on individual initiative. The result has been predictable: wide variation in performance, missed opportunities for donation, preventable loss of transplantable organs, and avoidable suffering for patients on waiting lists. DRH addresses this gap by providing the first comprehensive, hospital‑level framework that unifies clinical practice, governance, data, ethics, and public trust into a single, coherent system.

Across the preceding sections, this document has demonstrated that DRH is clinically necessary, operationally feasible, professionally aligned, economically compelling, ethically robust, and internationally compatible. It strengthens early recognition, standardises referral, stabilises donor physiology, protects families through specialist‑led communication, and ensures that brain‑death determination is timely, independent, and legally compliant. It reduces cognitive load for clinicians, prevents crises, improves coordination, and shifts accountability from individuals to institutions. It embeds governance, audit, and continuous improvement into the core of hospital practice. It aligns with the strongest elements of global best practice while addressing the gaps that existing systems have not yet resolved.

The economic case for DRH is equally compelling. With modest implementation costs and minimal new staffing requirements, DRH generates large, recurring savings through increased transplantation, reduced ICU utilisation, improved OR efficiency, and reduced litigation risk. At national scale, DRH delivers hundreds of millions of euros in annual savings while simultaneously improving survival, quality of life, and equity of access. Few health‑system interventions offer such a powerful combination of human and economic benefit.

DRH is also ethically and legally secure. It reinforces existing laws, strengthens consent processes, protects vulnerable families, and ensures transparent separation of roles. Its governance structures provide oversight, accountability, and public reassurance. Its alignment with WHO, EU, and international ethical frameworks ensures that it can be adopted confidently across diverse legal and cultural contexts.

Finally, DRH is a public‑trust model. It supports clinicians, respects families, integrates faith and cultural perspectives, and provides transparent performance reporting. It offers policymakers a high‑ROI, low‑risk strategy that strengthens national health systems and stabilises the transplant ecosystem. It offers hospitals a pathway to excellence. It offers clinicians clarity, support, and protection. And it offers patients something far more profound: a realistic chance at life.

Taken together, the evidence presented in this document demonstrates that DRH is not an incremental improvement but a system‑level transformation. It is the logical next step in the evolution of global donation policy—a model that unifies fragmented processes, reduces variation, and ensures that every hospital capable of supporting donation is consistently prepared, accountable, and aligned with the goal of saving lives. The path forward is clear: to move from aspiration to implementation, from isolated excellence to universal readiness, and from missed opportunities to a system in which every potential donor is recognised, supported, and honoured.

The Donor‑Ready Hospital model provides the framework. The next step is adoption.

References

Australian Organ and Tissue Authority. (2022). Annual Report 2021–22. Australian Government. https://www.donatelife.gov.au/sites/default/files/2022-11/OTA%20Annual%20Report%202021-2022.pdf

CORE (Center for Organ Recovery & Education). (2009). Organ Donation Toolbox. https://www.organdonationalliance.org/resources/toolbox/

Domínguez-Gil B, et. al. (2017). ACCORD-Spain study group.. Expanding the Donor Pool Through Intensive Care to Facilitate Organ Donation: Results of A Spanish Multicenter Study. Transplantation. 2017 Feb 23. https://doi.org/10.1097/TP.0000000000001701

MacKenzie, E. J., Rivara, F. P., Jurkovich, G. J., et al. (2006). A national evaluation of the effect of trauma center care on mortality. New England Journal of Medicine, 354(4), 366–378. https://www.nejm.org/doi/full/10.1056/NEJMsa052049

Matesanz, Rafael & Dominguez-Gil, Beatriz. (2007). Strategies to optimize deceased organ donation. Transplantation Reviews. 21. https://doi.org/10.1016/j.trre.2007.07.005

NHS Transplant Activity Report (2026). https://www.organdonation.nhs.uk/about-organ-donation/statistics-about-organ-donation/transplant-activity-report/

ODT Clinical – NHS Blood and Transplant. (2023). Donor optimisation. Guidance around selecting potential DBD donors https://www.odt.nhs.uk/deceased-donation/best-practice-guidance/donor-optimisation/

Israni A, et.al. (2025). OPTN/SRTR 2023 Annual Data Report: Deceased Organ Donation. American Journal of Transplantation, 25, S490-S517. https://www.amjtransplant.org/article/S1600-6135(25)00032-2/fulltext
 
Rees, K., McLaughlin, L., Paredes Zapata, D., et al. (2024). Qualitative content and discourse analysis comparing the current consent systems for deceased organ donation in Spain and England. Transplant International, 37, 12533. https://doi.org/10.3389/ti.2024.12533

Sheehy, E., Conrad, S. L., Brigham, L. E., et al. (2003). Estimating the number of potential organ donors in the United States. New England Journal of Medicine, 349(7), 667–674. https://www.nejm.org/doi/full/10.1056/NEJMsa021271

The Lancet. (2024). Organ donation: lessons from the Spanish model. The Lancet, 404(10459), 1171. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)02128-7/fulltext

U.S. Department of Health and Human Services (HHS). (2019). Advancing American Kidney Health. https://aspe.hhs.gov/sites/default/files/private/aspe-files/262056/advancingamericankidneyhealth.pdf

Vail, E. A., Goyal, V. K., McGinity, A. C., et al. (2025). Best practices for hospital‑based donor care unit operations. CHEST Critical Care, 3(2), 100144. https://www.chestcc.org/article/S2949-7884(25)00017-6/fulltext

If you’re interested in the DRH model, I would welcome a discussion.

Share this page

Licence: All ideas and concepts shown on this website are shared under the Creative Commons Attribution 4.0 International Licence (CC BY 4.0) . You are free to use, adapt, and build upon them, provided you give appropriate credit to Dr. Patrick Reynolds and include a link to this website.
© 2026 Patrick Reynolds